Back
Results - Announcements
Sales decline 9.81% to Rs 14.07 crore
Sandu Pharmaceuticals consolidated net profit declines 44.07% in the March 2025 quarter
29-May-2025, 07:36
Net profit of Sandu Pharmaceuticals declined 44.07% to Rs 0.33 crore in the quarter ended March 2025 as against Rs 0.59 crore during the previous quarter ended March 2024. Sales declined 9.81% to Rs 14.07 crore in the quarter ended March 2025 as against Rs 15.60 crore during the previous quarter ended March 2024.
Net profit of Sandu Pharmaceuticals declined 44.07% to Rs 0.33 crore in the quarter ended March 2025 as against Rs 0.59 crore during the previous quarter ended March 2024. Sales declined 9.81% to Rs 14.07 crore in the quarter ended March 2025 as against Rs 15.60 crore during the previous quarter ended March 2024.
For the full year,net profit rose 6.16% to Rs 1.55 crore in the year ended March 2025 as against Rs 1.46 crore during the previous year ended March 2024. Sales declined 0.13% to Rs 67.19 crore in the year ended March 2025 as against Rs 67.28 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
| Sales | 14.07 | 15.60 | -10 | 67.19 | 67.28 | 0 |
| OPM % | 3.20 | 3.85 | - | 4.11 | 3.42 | - |
| PBDT | 0.49 | 0.91 | -46 | 2.83 | 2.66 | 6 |
| PBT | 0.34 | 0.72 | -53 | 2.16 | 2.07 | 4 |
| NP | 0.33 | 0.59 | -44 | 1.55 | 1.46 | 6 |
Powered by Capital Market - Live News